Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,008,500 | 2,375,000 | 1,049,900 | 3,419,300 | 2,261,400 |
| Marketable Securities | 807,200 | N/A | N/A | 1,473,500 | 1,541,100 |
| Receivables | 1,342,400 | 1,404,800 | 1,664,100 | 1,705,000 | 1,549,400 |
| Inventories | 2,168,100 | 2,460,500 | 2,527,400 | 1,344,400 | 1,351,500 |
| Other current assets | 1,647,900 | 1,216,500 | 1,617,900 | 1,849,000 | 1,153,100 |
| TOTAL | $8,974,100 | $7,456,800 | $6,859,300 | $9,791,200 | $7,856,500 |
| Non-Current Assets | |||||
| PPE Net | 3,055,400 | 3,181,300 | 3,309,700 | 3,298,600 | 3,416,400 |
| Investments And Advances | 1,182,500 | 560,500 | 745,000 | 2,234,900 | 2,831,500 |
| Intangibles | 15,669,600 | 16,170,100 | 14,582,200 | 7,599,100 | 7,982,400 |
| Other Non-Current Assets | 557,900 | 680,600 | 1,348,600 | 1,630,300 | 1,790,500 |
| TOTAL | $20,465,400 | $20,592,500 | $19,985,500 | $14,762,900 | $16,020,800 |
| Total Assets | $29,439,500 | $28,049,300 | $26,844,800 | $24,554,100 | $23,877,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 432,000 | 424,200 | 403,300 | 491,500 | 589,200 |
| Accrued Expenses | 2,802,600 | 2,807,700 | 2,623,600 | 2,521,400 | 2,535,200 |
| TOTAL | $3,349,400 | $5,528,800 | $3,434,300 | $3,272,800 | $4,298,200 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,286,800 | 4,547,200 | 6,788,200 | 6,281,000 | 6,274,000 |
| Other Non-Current Liabilities | 1,038,900 | 1,066,800 | 1,180,700 | 1,362,500 | 1,479,400 |
| TOTAL | $7,833,300 | $5,804,500 | $8,611,100 | $7,892,900 | $8,619,400 |
| Total Liabilities | $11,182,700 | $11,333,300 | $12,045,400 | $11,165,700 | $12,917,600 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 146,759 | 146,375 | 145,361 | 144,486 | 146,963 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | 20,552,700 | 19,259,800 | 17,627,600 | 16,466,500 | 13,911,700 |
| Other shareholders' equity | -182,100 | -136,300 | -153,800 | -174,500 | -43,300 |
| TOTAL | $18,256,800 | $16,716,000 | $14,799,400 | $13,388,400 | $10,959,700 |
| Total Liabilities And Equity | $29,439,500 | $28,049,300 | $26,844,800 | $24,554,100 | $23,877,300 |